Evidence map›Paper›PMID 33918338›Full record

ArticleGenes2021

Ewelina Szczerba, Katarzyna Kamińska, Tomasz Mierzwa, Marcin Misiek, Janusz Kowalewski, Marzena Anna Lewandowska

Open access · goldAbstract read
In one paragraph

Article in Genes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ewelina SzczerbaThe F. Lukaszczyk Oncology Center, Molecular Oncology and Genetics Department, Innovative Medical Forum, 85-796 Bydgoszcz, Poland.
Katarzyna KamińskaThe F. Lukaszczyk Oncology Center, Molecular Oncology and Genetics Department, Innovative Medical Forum, 85-796 Bydgoszcz, Poland.
Tomasz MierzwaThe F. Lukaszczyk Oncology Center, Department of Prevention and Health Promotion, 85-796 Bydgoszcz, Poland.
Marcin MisiekŚwiętokrzyskie Cancer Center, Clinical Department of Gynaecological Oncology, 25-734 Kielce, Poland.
Janusz KowalewskiDepartment of Thoracic Surgery and Tumors, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, 85-067 Torun, Poland.
Marzena Anna LewandowskaThe F. Lukaszczyk Oncology Center, Molecular Oncology and Genetics Department, Innovative Medical Forum, 85-796 Bydgoszcz, Poland.ORCID 0000-0002-7360-7810
Nicolaus Copernicus University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: Although, in the mutated

Indexed as

MutationAdultAgedBRCA1 ProteinBRCA2 ProteinBreast NeoplasmsComputational BiologyFemaleGenetic Predisposition to DiseaseGerm-Line MutationHigh-Throughput Nucleotide SequencingHumansMiddle AgedPolandSequence Analysis, DNABRCA1 ProteinBRCA1 protein, humanBRCA2 Proteinbioinformatic NGS softwareBRCA 1/2 geneshereditary breast cancernext-generation sequencingsomatic BRCA variantTNBC patients

Identifiers

PMID33918338
PMCPMC8065856
OpenAlexW3142503736

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.